Delivery Order SPE2DR25D2003-SPE2DR26FQ94L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with a ceiling value of $6,696.44. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete openly in federal pharmaceutical procurement. The contract is set to be completed by November 4, 2025, and will be performed at the contractor's facility in...
- The Defense Logistics Agency (DLA) awarded a $11,545.91 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,080.32. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $32,074.46 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 15, 2025, with completion expected by September 16, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement supporting military and federal healthcare operations. The award was executed under a competitive process, consistent with AmerisourceBergen's established role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,449.50 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitive, firm fixed-price delivery order will be fulfilled at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $68,990 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed price delivery order supports the federal government's pharmaceutical supply chain with no set-aside designation applied. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.85 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 5, 2025, with completion expected by August 6, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-competitive, non-set-aside award is scheduled for completion by October 22, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction under AmerisourceBergen's larger federal contract portfolio supporting military and defense healthcare...
- The Defense Logistics Agency awarded a $6,257.43 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 6, 2025, with completion targeted for August 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FQ94LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,684.46 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price contract, which involves no set-aside designation, represents a competitive award supporting federal medical procurement needs. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive range of medical products to support military and federal healthcare systems globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical supply requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 11/4/25 |